Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Gilead Sciences has halted Phase 2/3 trials of its investigational once-weekly oral HIV therapy, WONDERS-2, following an eight-month FDA clinical hold. This regulatory pause prioritizes patient safety over speed, addressing ... Read More
Continuous Coverage
Cooper University Health Care is expanding its cardiovascular support infrastructure in Cape May Court by recruiting Registered Nurses…
Alan Ritchson, the star of Amazon Prime Video’s Reacher, is currently facing serious allegations regarding a physical assault…
The Keeneland Spring Meet opens in Lexington, Kentucky, marking the critical final preparatory phase for the Kentucky Derby.…
The Galaxy S26 now natively supports Apple’s AirDrop protocol via a backend update to Samsung’s Quick Share, enabling…
The U.S. Economy added 178,000 jobs in March, exceeding forecasts and providing the Federal Reserve with the economic…
The smoke has barely cleared over the border ridge, but the silence following this latest strike is louder…
Global Affairs
A US-based mercenary group, allegedly paid $1.5 million monthly by the United Arab Emirates, has been linked to…
Markets And Money
Marjan Rintel, CEO of KLM Royal Dutch Airlines, has secured a revised compensation package reflecting the Air France-KLM…
Digital Culture
Seize-Two Interactive has dissolved its dedicated AI division as of April 2026, signaling a strategic retreat from generative…
Science And Wellbeing
Researchers are enhancing CAR T-cell therapy by “armoring” cells with Interleukin-12 (IL-12) to penetrate solid tumors. This approach…
Screen And Sound
The Uffizi Gallery in Florence confirmed a cyber-attack this week, though officials deny any data breach occurred. While…
Fixtures And Form
